-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $28 Price Target

Benzinga·03/24/2025 11:01:18
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $28 price target.